🔎 Trials Near Me

Dachaigh › Myelofibrosis › Massachusetts › Boston

Sgrùdaidhean clionaigeach Myelofibrosis ann an Boston, MA

Tha 12 sgrùdaidhean airson Myelofibrosis a’ lorg phàirtichean aig làraichean ann agus timcheall air Boston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

A’ fastadhÌre 1/2
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04176198

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

A’ fastadhÌre 3
  • Tufts Medical Center, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07623161

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

A’ fastadhÌre 1
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06343805

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

A’ fastadhÌre 1/2
  • Massachusetts General Hospital (Data Collection Only), Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT06773195

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
  • Brigham and Women's Hospital, Boston
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07020533

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

A’ fastadhÌre 1
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT07441694

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

A’ fastadhÌre 1
  • Dana Farber Cancer Institute, Boston
Aoisean 13 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT04771572

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

A’ fastadhÌre 1
  • Dana Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Gibl 2026 · NCT06034002

Momelotinib During and After HCT in Myelofibrosis

A’ fastadhÌre 1
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Màrt 2026 · NCT07104799

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
  • DFCI/BWH Brigham and Women's Hospital, Boston
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 10 Màrt 2026 · NCT06059391

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

A’ fastadhÌre 3
  • Dana Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2025 · NCT06479135

Sgrùdaidhean Myelofibrosis ann am bailtean eile

Sgrùdaidhean eile ann an Boston

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.